Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03289390 · ClinicalTrials.gov registry record
Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications
A clinical trial, sponsored by Albany Medical College.
- Completed
- Registry status
- 11
- Enrollment target
NCT03289390 is a clinical trial that has completed, run by Albany Medical College. The registered enrollment target is 11 participants.
The verdict
NCT03289390 has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This study will evaluate the use of acetaminophen in preterm infants when a patent ductus arteriosus (PDA) is of concern. We will perform two simultaneous prospective observational studies over a 3 year period. The first will be of infants with clinically significant PDAs beyond 14 days of life who are medically treated with acetaminophen as a means to avoid surgical ligation, and the second will be of infants who received acetaminophen for a PDA closure during the first 2 weeks of life as a result of ibuprofen, the current standard of care in our NICU, contraindication due to medical status.
Interventions
- DRUG Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03289390
The ClinicalTrials.gov registry entry for NCT03289390 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acetaminophen is the first listed.
NCT03289390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03289390 about?
NCT03289390 is a clinical study titled "Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications". This study will evaluate the use of acetaminophen in preterm infants when a patent ductus arteriosus (PDA) is of concern. We will perform two simultaneous prospective observational studies over a 3 year period. The first will be of infants with clinically significant PDAs beyond 14 days of life who ...
What is the current status of trial NCT03289390?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2017-08-01. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03289390?
The interventions under investigation include: Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT03289390?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.